Frankfurt-am-Main, Germany

Heinz G Ogelein


Average Co-Inventor Count = 5.6

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Heinz G Ogelein: Innovator in Cardiovascular Pharmaceuticals

Introduction

Heinz G Ogelein is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that exhibit beneficial effects on the cardiovascular system. With a total of 3 patents to his name, Ogelein's work has garnered attention in the scientific community.

Latest Patents

Ogelein's latest patents focus on substituted benzenesulfonylureas and -thioureas. These compounds are characterized by their outstanding effects on the cardiovascular system. His inventions include processes for the preparation of these compounds, which have demonstrated antiarrhythmic activity. The compounds of formula I, as defined in his specifications, are poised to offer new therapeutic options in cardiovascular treatment.

Career Highlights

Heinz G Ogelein is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Hoechst has allowed him to explore innovative solutions in drug development, particularly in the area of cardiovascular health.

Collaborations

Ogelein has collaborated with notable colleagues such as Heinrich Christian Englert and Uwe Gerlach. These partnerships have contributed to the advancement of research and development in the pharmaceutical sector.

Conclusion

Heinz G Ogelein's contributions to the field of cardiovascular pharmaceuticals highlight his innovative spirit and dedication to improving health outcomes. His patents and collaborative efforts continue to influence the landscape of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…